The Difference Between a Structured Document and Structured Content Authoring
Explore the transition from structured documents to dynamic, modular structured content authoring for enhanced content value, automation, and reuse.
7 Ways to Write for Content Reuse Even Before You Have Structured Content Authoring
The following guidelines will help you build your skills and deepen your understanding of why structure requires us to change how we write.
5 Tips for Selecting Your First Pharma SCA Use Case
Pharma companies are under pressure to improve the quality and efficiency of their content. Learn how to select your first SCA use case.
Lowering Risk in Pharma With Structured Content Authoring: What You Need to Know
To automate content development, pharmaceutical companies must move to structured content authoring.
Pharma Deserves Better
Legacy tools and processes no longer support the business objectives for pharma. The only way to meet the growing demands for more content, faster, is to adopt a structured content ecosystem.
There’s No Such Thing as a Perfect Structure
There is no such thing as a perfect structure because it is going to change over time. With new products and services should come new content types. And new content types often require new structures.
10 Ways an SCM Optimizes Your CDS
There are many reasons why a component structured content management (SCM) system is superior to using a Microsoft Word document for managing your Company Core Data Sheet (CDS or CCDS). We touched upon some of the reasons in our previous blog post, The CDS is Dead! Long Live the CDS!
The CDS is Dead! Long Live the CDS!
The Company Core Data Sheet (CDS or CCDS) is one of the most important documents a pharmaceutical company creates. The CDS is a working document that contains information about the pharmaceutical product. It includes information from multiple sources, such as clinical trial data systems, clinical report documents, CMC data systems,
How to Create a Unified Content Experience
After decades (literally) of talking about silos, calmly and not so calmly explaining to people why they are problematic, and advocating for their demise, I have come to the (obvious) conclusion that we are not going to eliminate them any time soon. If you already figured this out, you are
Getting Granular with eCTD v4.0
We talk a lot about the goal of enterprise content strategy for pharma: to help speed up the process of making safe, effective medicines.
Buy this Book to learn exactly what it takes to deliver personalized experiences at scale.
our recent posts
Get exclusive access to Val’s thoughts and hand-picked content with our newsletter.
“*” indicates required fields
browse by topic
- Additional Resources (3)
- AI Readiness (10)
- Artificial Intelligence (4)
- Blogs (117)
- Books (1)
- Content Development (45)
- Content Management (5)
- Content Quality (20)
- Content Strategy (100)
- Content Transformation (22)
- Conversational AI (1)
- eBooks (6)
- Global Readiness (5)
- Good Words (2)
- Knowledge Management (1)
- Personalization (19)
- Pharmaceutical (32)
- Recordings (14)
- Regulatory Compliance (1)
- Structured Content (3)
- White Papers (5)
- Workplace Practices (1)